Oncotarget

Research Papers:

MT2-MMP induces proteolysis and leads to EMT in carcinomas

Yusi Liu, Xiaojiao Sun, Jinfa Feng, Li-Li Deng, Yihao Liu, Bokang Li, Mingyue Zhu, Changlian Lu _ and Lingyun Zhou

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:48193-48205. https://doi.org/10.18632/oncotarget.10194

Metrics: PDF 1627 views  |   HTML 2424 views  |   ?  


Abstract

Yusi Liu1,*, Xiaojiao Sun2,*, Jinfa Feng3,*, Li-Li Deng4, Yihao Liu1, Bokang Li1, Mingyue Zhu1, Changlian Lu1, Lingyun Zhou5

1Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University, Harbin, China

2Department of Pathophysiology, Harbin Medical University, Harbin, China

3Department of General Surgery, Heilongjiang Province Hospital, Harbin, China

4Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

5Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China

*These authors have contributed equally to this work

Correspondence to:

Changlian Lu, email: [email protected]

Lingyun Zhou, email: [email protected]

Keywords: MT2-MMP, cancer, epithelial-mesenchymal transition (EMT), E-cadherin, zonula occludens-1 (ZO-1)

Received: January 20, 2016    Accepted: June 09, 2016    Published: June 21, 2016

ABSTRACT

Epithelial-mesenchymal transition (EMT) is critical for carcinoma invasiveness and metastasis. To investigate the role of membrane-type-2 matrix metalloproteinase (MT2-MMP) in EMT, we generated lentiviral constructs of wild-type (WT) and an inactive Glu260Ala (E260A) mutant MT2-MMP and derived stably transfected HCT116 and A549 cell lines. WT-transfected cells appeared mesenchymal-like, whereas cells transfected with the E260A mutant were epithelial-like, as were cells treated with an MMP inhibitor (GM6001). Expression of E-cadherin, β-catenin, and zonula occludens-1 was lower in cells transfected with WT MT2-MMP compared to vector controls, cells treated with GM6001, or cells transfected with the E260A mutant. An 80-kD N-terminal fragment of E-cadherin was immunoprecipitated in conditioned medium from WT MT2-MMP cells, but not in the medium from vector controls, cells treated with GM6001, or E260A mutant cells. When endogenous expression of MT2-MMP in A2780 human ovarian cancer cells was inhibited using GM6001 or MT2-MMP-specific siRNA, levels of the 80-kD E-cadherin fragment in conditioned medium were decreased. Chick embryo chorioallantoic membrane invasion assays demonstrated that cells transfected with WT MT2-MMP were more invasive than cells transfected with control vector, treated with GM6001, or transfected with the E260A mutant. These results suggest that MT2-MMP degrades adherens and tight junction proteins and results in EMT, making it a potential mediator of EMT in carcinomas.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 10194